These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma. Griffin TW, Richardson C, Houston LL, LePage D, Bogden A, Raso V. Cancer Res; 1987 Aug 15; 47(16):4266-70. PubMed ID: 3496960 [Abstract] [Full Text] [Related]
44. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer. Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA. Br J Cancer Suppl; 1991 Jun 15; 14():71-3. PubMed ID: 1645577 [Abstract] [Full Text] [Related]
45. Evaluation of ricin A chain-containing immunotoxins directed against different epitopes on the delta-chain of cell surface-associated IgD on murine B cells. May RD, Finkelman FD, Wheeler HT, Uhr JW, Vitetta ES. J Immunol; 1990 May 01; 144(9):3637-42. PubMed ID: 1691764 [Abstract] [Full Text] [Related]
46. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. Till M, May RD, Uhr JW, Thorpe PE, Vitetta ES. Cancer Res; 1988 Mar 01; 48(5):1119-23. PubMed ID: 3257712 [Abstract] [Full Text] [Related]
47. Antigenic modulation by anti-CD5 immunotoxins. Manske JM, Buchsbaum DJ, Azemove SM, Hanna DE, Vallera DA. J Immunol; 1986 Jun 15; 136(12):4721-8. PubMed ID: 3086441 [Abstract] [Full Text] [Related]
49. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice. Roth JA, Ames RS, Fry K, Lee HM, Scannon PJ. Cancer Res; 1988 Jun 15; 48(12):3496-501. PubMed ID: 3259469 [Abstract] [Full Text] [Related]
50. Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics. van Oosterhout YV, Preijers FW, Wessels HM, de Witte T. Cancer Res; 1992 Nov 01; 52(21):5921-5. PubMed ID: 1394218 [Abstract] [Full Text] [Related]
52. Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity. Woo BH, Lee JT, Lee KC. Arch Pharm Res; 1994 Dec 01; 17(6):452-7. PubMed ID: 10319157 [Abstract] [Full Text] [Related]
55. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin. Griffin TW, Pagnini PG, Houston LL. J Biol Response Mod; 1987 Oct 01; 6(5):537-45. PubMed ID: 3500277 [Abstract] [Full Text] [Related]
58. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S, Houston LL. Cancer Res; 1984 Apr 01; 44(4):1398-404. PubMed ID: 6142765 [Abstract] [Full Text] [Related]
59. Selective killing of human bladder cancer cells by combined treatment with A and B chain ricin antibody conjugates. Thiesen HJ, Juhl H, Arndt R. Cancer Res; 1987 Jan 15; 47(2):419-23. PubMed ID: 3539323 [Abstract] [Full Text] [Related]
60. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents. Woo BH, Lee JT, Park MO, Lee KR, Han JW, Park ES, Yoo SD, Lee KC. Arch Pharm Res; 1999 Oct 15; 22(5):459-63. PubMed ID: 10549572 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]